MARKHAM, ON, March 23, 2015 /CNW/ - Nightingale Informatix
Corporation ("Nightingale" or the "Company") (TSX-V: NGH), a
cloud-based provider of electronic health record (EHR) software and
related services, today announced a limited commercial release of
Nightingale Version 10 (v10) for the purpose of migrating its
US client base currently using its Medrium practice management
product.
"The commercial release of Nightingale v10 is another
substantial milestone for our valued Customers and the Company"
said Sam Chebib, President and CEO
of Nightingale. "This release is targeted to migrate our
Medrium client base and will be generally available to other US
physicians and Revenue Cycle Management businesses to automate the
business management components of their practices. Our next
generation product, v10, builds on Nightingale's 12 years of
experience and is based upon a state of the art technology
platform. Well in advance of the October 1, 2015 deadline for the transition from
ICD-9 to ICD-10 codes, Nightingale v10 Practice Management has
completed end-to-end testing with US payers including dual coding
(ICD-9 and ICD-10). v10 provides robust functionality through
a clean, intuitive interface providing improved productivity,
efficiency and effectiveness to users."
Over the past several months, Nightingale v10 has been piloted
and demonstrated to existing clients and the migration of several
hundred users to our next generation product has commenced.
"We continue to believe that the North American EMR market is
crowded with legacy products and that Nightingale v10 has clear
differentiators that will separate it from first and second
generation products in the market today" added Chebib. "Over the
past 30 months we have proactively invested over $15 million to design and build Nightingale v10
with input from our customers and the market at large. The feedback
from both current and prospective users is extremely positive and
very encouraging."
Nightingale is also planning the next release of v10 in the
summer of 2015. This will be available to all Canadian and US
clients including its 20,000 valued users who manage 18 million
patient records on its current platforms. The Company is also
confident those who have not yet selected an EMR and those who are
looking for a third generation EMR will find considerable value in
Nightingale v10.
About Nightingale
For more than a decade, Nightingale (TSX-V: NGH) has been
delivering innovative cloud-based Electronic Health Record (EHR)
and Practice Management solutions to healthcare organizations
across the United States and
Canada. Our goal is to
uncomplicate the day-to-day challenges of healthcare providers. We
achieve this by creating software that is truly
intuitive—minimizing training and maximizing adoption. We believe
so strongly in building easy-to-use software that we structured our
entire product team around user-centric design. Our clients are
benefiting from this focus through a well-supported and robust
solution that presents a holistic view of a person's well-being in
a simple, clean interface, so that the best health decisions can be
made. Nightingale – One Patient.
One Record.
www.nightingalemd.com
Forward Looking Statement
This press release contains "forward-looking statements"
respecting the issuance and cancellation of securities of the
Corporation within the meaning of applicable Canadian securities
legislation. Generally, forward-looking statements can be
identified by the use of forward- looking terminology such as
"plans", "expects" or "does not expect", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or state that certain actions, events or results "may"
,"could", "would", "might", "occur" or "be achieved".
Forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of Nightingale to be
materially different from those expressed or implied by such
forward-looking statements, including but not limited to: risks
related to the speculative nature of the medical software industry,
which is affected by numerous factors beyond Nightingale's control;
the ability of Nightingale to successfully secure customer
contracts and the timing of securing such contracts; the ability of
Nightingale to complete and successfully integrate its acquisitions
on an accretive basis, Nightingale's access to debt and capital
facilities, including compliance with current debt arrangements;
the existence of present and possible future government regulation;
the significant competition that exists in the medical software
industry; the early stage of Nightingale's business, and risks
associated with early stage companies, including uncertainty of
revenues, markets and profitability and the need to raise
additional funding. All material assumptions used in making
forward-looking statements are based on management's knowledge of
current business conditions and expectations of future business
conditions and trends. Certain material factors or assumptions
applied by management in making forward-looking statements, include
without limitation, factors and assumptions regarding future trends
in healthcare spending, economic conditions affecting Nightingale
and North American economies; Nightingale's ability to continue to
fund its business, rates of customer defaults, relationships with,
and payments to lenders, as well as Nightingale's operating cost
structure.
Although Nightingale has attempted to identify important
factors that could cause actual results to differ materially from
those contained in forward-looking statements, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements. Nightingale does not undertake to update any
forward-looking statements that are incorporated by reference
herein, except in accordance with applicable securities laws.
Further information on Nightingale Informatix Corporation is
available at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Nightingale Informatix Corporation